This site is intended for healthcare professionals only
LoginRegister
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs
Export Council PHARMEXCIL Holds Strategic Talks with Govt on Scaling USD 30.47 Billion Pharma ExportsExport Council PHARMEXCIL Holds Strategic Talks with Govt on Scaling USD 30.47 Billion Pharma...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity DrugsEli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealEli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal
RUHS Declares D Pharmacy Results 2025, Scorecards Now Available OnlineRUHS Declares D Pharmacy Results 2025, Scorecards Now Available Online
Centre Reviews GTE Exemption for 11 Specialty Drugs, Domestic Pharma Asked to Raise ObjectionsNo More Court Trials for Pharma Firms in Minor Drug Law Violations
Biocon Employee Passes Away in Suspected Workplace SuicideBiocon Employee Passes Away in Suspected Workplace Suicide
Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine AlertsAbhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts
Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSCBiocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors
Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA ActionHaryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA Action
Antibiotics May Soon Carry Blue Strip as Health Ministry Moves to Fight AMRHealth Ministry Mulls Extension for Pharma Firms to Comply with Revised Schedule M GMP Norms
X